In this review, the expression pattern, regulatory roles and patterns, mechanistic pathways, and interactions of key molecules that are associated with lncRNA UCA1 in GI cancer progression and chemoresistance, including EC, GC, hepatobiliary cancer, PC, and CRC, are summarized (Table 1). This evidence concerns the gene UCA1 and colorectal carcinoma.